{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/ai-no-longer-bottleneck-why-clinical-development-must-shift-innovation-execution#webpage",
"url": "https://www.fortrea.com/insights/ai-no-longer-bottleneck-why-clinical-development-must-shift-innovation-execution",
"name": "AI is No Longer the Bottleneck: Why Clinical Development Must Shift from Innovation to Execution",
"description": "This Fortrea article explores why clinical development must move beyond artificial intelligence experimentation and focus on disciplined clinical trial execution to achieve meaningful improvements in trial delivery. While AI has become increasingly embedded within healthcare and clinical research, the industry continues to face challenges translating innovation into measurable operational impact. Drawing on insights from the Fortrea Intelligent Technology (FIT) Summit, the article argues that future success will depend on embedding intelligence directly into clinical development workflows, governance models, and operational practices rather than layering technology onto existing processes. Key themes include study start-up optimization, operational intelligence, sponsor-site burden reduction, clinical data interoperability, workflow integration, and the importance of preserving data meaning across systems to support confident decision-making. The article highlights how reducing the time between scientific discovery, patient impact, meaningful insight generation, and clinical execution requires scalable operating models, connected workflows, and reliable execution frameworks that enable clinical development teams to deliver predictable results, accelerate timelines, and improve outcomes for sponsors, sites, and patients."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "AI is No Longer the Bottleneck: Why Clinical Development Must Shift from Innovation to Execution",
"item": "https://www.fortrea.com/insights/ai-no-longer-bottleneck-why-clinical-development-must-shift-innovation-execution"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry - as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/ai-no-longer-bottleneck-why-clinical-development-must-shift-innovation-execution#article",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/ai-no-longer-bottleneck-why-clinical-development-must-shift-innovation-execution#webpage"
},
"headline": "Clinical Trial Execution: AI, Operational Intelligence & Interoperability | Fortrea Article",
"description": "This Fortrea article explores why clinical development must move beyond artificial intelligence experimentation and focus on disciplined clinical trial execution to achieve meaningful improvements in trial delivery. While AI has become increasingly embedded within healthcare and clinical research, the industry continues to face challenges translating innovation into measurable operational impact. Drawing on insights from the Fortrea Intelligent Technology (FIT) Summit, the article argues that future success will depend on embedding intelligence directly into clinical development workflows, governance models, and operational practices rather than layering technology onto existing processes. Key themes include study start-up optimization, operational intelligence, sponsor-site burden reduction, clinical data interoperability, workflow integration, and the importance of preserving data meaning across systems to support confident decision-making. The article highlights how reducing the time between scientific discovery, patient impact, meaningful insight generation, and clinical execution requires scalable operating models, connected workflows, and reliable execution frameworks that enable clinical development teams to deliver predictable results, accelerate timelines, and improve outcomes for sponsors, sites, and patients.",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2026-05/ai-clinical-execution-banner.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2026-05-14",
"dateModified": "2026-05-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-05/ai-clinical-execution-banner.pdf",
"encodingFormat": "application/pdf"
}
}
]
}